Aurinia Pharmaceuticals (AUPH) Surpasses Q3 Earnings and Revenue Estimates

Aurinia Pharmaceuticals (AUPH) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.1 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +43.75%. A quarter ago, it was expected that this biotechnology company would post earnings of $0.17 per share when it actually produced earnings of $0.16, delivering a surprise of -5.88%.Over the last four ...